ACN Newswire Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy
ACN Newswire Spritzer Clinches 10th Consecutive “Brand of the Year” Award at the World Branding Awards in London
ACN Newswire CleverTap Report: 46% of Product Managers Cite Resource Limitations as Top Barrier to App and Web Experimentation
ACN Newswire eBRAM Partners with Agency for Volunteer Service to Launch ‘Pro-Bono Online Mediation Scheme for Water Seepage Disputes’
ACN Newswire China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia
ACN Newswire Advancing the Belt and Road Initiative: The Kyrgyz Republic Ministry of Finance’s First Promotional Seminar and Non-Deal Roadshow Successfully Held
ACN Newswire Military Metals Completes Claim Staking Around the Last Chance Antimony-Gold Property in Nevada
ACN Newswire Hua Medicine Announces Successful U.S. Phase I Results on Its 2nd Generation GKA Candidate
